Nivolumab,vusolimogene,rp2,rp-1
BMS,Replimune
['pilot', 'thank you', 'ignyte', 'replimune']
thank you for inviting us to your reception. very exciting prelim data from the ignyte trial. fingers crossed we can replicate this data in our pilot study incredibly grateful for for her continuous support and mentorship! #asco23 
PGY 2 @PittGIM丨Researcher @MDALeukemia丨MD’19 @AUB_Lebanon丨🇱🇧 🇨🇦 🇦🇪丨Opinions = Spectacular, retweet ≠ endorsement